NLS Pharmaceutics AG (NLSP)

1.78

-0.06 (-3.26%)

At close: Mar 03, 2025, 3:59 PM

1.77

-0.56%

After-hours: Mar 03, 2025, 05:14 PM EST

NLS Pharmaceutics AG Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15M	-6.66M
Depreciation & Amortization	11.41K	11.41K	10.05K	72.19M	n/a	1.09M	n/a
Stock-Based Compensation	164.91K	22.73K	n/a	n/a	n/a	n/a	77.91
Other Working Capital	-8.54K	990.55K	-875.26K	580.48K	2.74M	143K	-9.79K
Other Non-Cash Items	59.53K	364.64K	166.51K	-72.12M	1.14M	1.22M	884.31K
Deferred Income Tax	n/a	613.42K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.25M	1.63M	-3.17M	2.06M	4.12M	101.9K	340.29K
Operating Cash Flow	-9.68M	-13.88M	-14.94M	-729.39K	-190.01K	-2.73M	-5.43M
Capital Expenditures	-4	n/a	-39.56K	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	-3.51M	-39.56K	225.64K	-217.25K	n/a	n/a
Debt Repayment	1.63M	825.84K	-2.1M	1.19M	154.89K	n/a	3.45M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	7.35M	7.89M	-686.7K	252.59K	557.92K	3.28M
Financial Cash Flow	1.63M	17.4M	20.34M	503.52K	407.48K	557.92K	6.73M
Net Cash Flow	-8.05M	3.52M	5.34M	-126.56K	213.59K	-2.18M	1.3M
Free Cash Flow	-9.68M	-13.88M	-14.98M	-729.39K	-190.01K	-2.73M	-5.43M